James Hok‐Leung Tsu

University of Hong Kong, Chinese University of Hong Kong

Papers

Total Citations

H-Index

About

Dr. James Hok-Leung Tsu is a leading urological surgeon and researcher whose work centers on the surgical management of prostate cancer, with a particular focus on outcomes and complications associated with robotic-assisted laparoscopic prostatectomy (RALP). His most cited work, a 2013 case report and literature review on trocar-site hernia at the 8-mm robotic port, has garnered 25 citations, highlighting his contribution to understanding and preventing rare but significant postoperative complications. This research underscores his dedication to refining surgical techniques and improving patient safety. In a more recent landmark study (2022), Dr. Tsu addressed a critical gap in the literature by analyzing long-term survival outcomes of radical prostatectomy in a 20-year Chinese single-institution series. With only 3 citations to date, this work provides invaluable, population-specific prognostic data, demonstrating that pathological and surgical information can guide treatment for localized prostate cancer in Asian patients. Dr. Tsu’s research bridges the gap between Western surgical standards and the unique clinical realities of Chinese cohorts, making him a pivotal figure in global urologic oncology.